Hutch News

Extending efficacy for CAR T-cell therapies

Extending efficacy for CAR T-cell therapies

Dr. Shivani Srivastava receives NCI MERIT Award to investigate how to improve engineered cancer immunotherapies against solid tumors through reservoirs of self-renewing immune cells
Hutch NewsOctober 09, 2023
Calling in the backup: expanding DCs to augment vaccine responses

Calling in the backup: expanding DCs to augment vaccine responses

From the Fling and Cheever CITN Central Immune Monitoring Lab, Vaccine and Infectious Disease Division and Clinical Research Division
Science SpotlightFebruary 15, 2021
Fred Hutch research to be presented at American Society of Hematology conference

Fred Hutch research to be presented at American Society of Hematology conference

Fred Hutch researchers to share latest research in immunotherapy, genetic markers, graft vs. host disease, cord blood and more
News ReleasesNovember 29, 2016
New clues to treating deadly skin cancer

New clues to treating deadly skin cancer

Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma
Hutch NewsJune 06, 2016
Got ideas for better, faster cancer cures?

Got ideas for better, faster cancer cures?

After Vice President Joe Biden’s Fred Hutch visit, we ask panelists for their ‘moonshot’ wish lists
Hutch NewsApril 15, 2016